Access brought to you by: LOCKSS

Diabetes & Endocrinology Clinical Trials

Efficacy of a Bihormonal Closed-Loop System to Control Postprandial and Post Exercise Glucose Excursions
Combined Intensive BP and Glycemic Control Has No Benefit in Reducing CV Risk in Patients with T2DM
Triple Therapy with Liraglutide + Metformin + Insulin Detemir Improves Glycemic Control with No Weight Gain and Low Rates of Hypoglycemia
Daily Insulin Dose at One Year Predicts Weight Gain in People with Type 2 Diabetes Newly Treated with Insulin
Liraglutide Reduces Insulin Dose without Affecting Glycemic Control in T1DM
TAK-875 Reduces HbA1C in Patients with T2DM
GH Replacement Improves CV Risk Factors in Viscerally Obese Premenopausal Women
Pasireotide May Provide Option for Medical Therapy Targeting the Underlying Cause of Cushing Disease
Treatment with GH May Be Associated with Increased Mortality
Transitioning to Denosumab from Continuous Alendronate Therapy Further Improves BMD in Postmenopausal Women with Osteoporosis

Pages